Thailand Life Sciences Gateway

Investment & Funding

Track investment activity, funding rounds, and deal flows in Thailand's life sciences ecosystem

Total Investment
฿47.2B
+23%from last year
Active Deals
234
+18%from last year
Investors
89
+31%from last year
Exits
45
+12%from last year
Total Investment
฿62.2B
Avg Deal Size
฿1.1M
Total Deals
57
Top Sector
Pharmaceuticals
Top Region
Bangkok
Growth Rate
+23.4%
Investment Flow Visualization
Investment Sources
Government Funding
฿12.5B
Venture Capital
฿18.3B
Angel Investors
฿6.8B
Corporate Ventures
฿15.2B
International Funds
฿9.4B
Investment Stages
Seed
฿8.5B
Series A
฿15.2B
Series B
฿18.6B
Growth
฿12.4B
IPO/Exit
฿7.5B
Industry Sectors
Pharmaceuticals
฿16.8B
Medical Devices
฿14.2B
Biotechnology
฿12.5B
Health Tech
฿9.8B
Diagnostics
฿8.9B
Geographic Regions
Bangkok
฿28.4B
Eastern Seaboard
฿15.8B
Northern Region
฿8.9B
Southern Region
฿6.2B
Central Region
฿2.9B
Key Investment Patterns
Government Leading Early Stage
Government funding dominates seed and Series A rounds, providing crucial early-stage support
Corporate Growth Focus
Corporate ventures concentrate on Series B and growth-stage investments
Bangkok Centralization
Over 45% of investments flow to Bangkok-based companies
Investment Opportunities
Regional Expansion
Significant potential in Northern and Southern regions for healthcare innovation
Digital Health Growth
Emerging sector with strong seed funding but room for later-stage investment
International Partnerships
Growing international interest, especially in late-stage and exit opportunities
Investment by Sector

Sector Distribution

฿47.2B

Total Investment

234 deals across sectors

Sector Breakdown

Biotechnology

92 active deals

฿18.4B

39% share

Medical Devices

67 active deals

฿12.8B

27% share

Digital Health

45 active deals

฿8.9B

19% share

Pharmaceuticals

23 active deals

฿4.2B

9% share

Others

7 active deals

฿2.9B

6% share

Top Investors

SCB 10X Ventures

Fintech & Healthcare

฿8.4B

23 investments

Kasikorn Vision

Deep Tech

฿6.2B

19 investments

CP Group Venture

Agtech & Biotech

฿4.8B

15 investments

True Digital Ventures

Digital Health

฿3.1B

12 investments

TCELS Venture Capital

Life Sciences

฿2.9B

18 investments

Recent Exits

ThaiPharma Analytics

Acquisition
Johnson & Johnson฿1.2B

2/15/2024

MediData Solutions

IPO
SET฿890M

1/8/2024

BioLab Innovations

Acquisition
Roche฿650M

12/22/2023

Company Valuation vs Investment Amount
Recent Investment Deals4 deals

BioPharma Innovations Co., Ltd.

Series BBiotechnologyGrowth

Led by SCB 10X Ventures

฿180M
$5.1M
3/15/2024

Leading the development of personalized CAR-T cell therapy for cancer treatment with breakthrough clinical results.

Valuation

฿750M

Employees

150

Patents

12

Revenue

฿45M

Investors

SCB 10X VenturesKasikorn VisionSingapore Life Sciences FundTCELS Venture Capital

Use of Funds

Clinical trials expansion
R&D enhancement
Market expansion
Team scaling

Funding History

Series AKasikorn Vision
฿45M
6/20/2022
SeedTCELS Venture Capital
฿12M
3/10/2020
5 partnerships
Growth stage

MedTech Solutions Ltd.

Series AMedical DevicesExpansion

Led by Krungthai Ventures

฿95M
$2.7M
1/22/2024

AI-powered medical devices for cardiovascular diagnosis with FDA breakthrough device designation.

Valuation

฿380M

Employees

75

Patents

8

Revenue

฿28M

Investors

Krungthai VenturesCP Group VentureTrue Digital VenturesNorthern Innovation Fund

Use of Funds

Product development
FDA approval process
Manufacturing scale-up
International expansion

Funding History

SeedNorthern Innovation Fund
฿18M
9/15/2021
12 partnerships
Expansion stage

Digital Health Innovations

SeedDigital HealthEarly

Led by True Digital Ventures

฿25M
$0.7M
11/8/2023

Mobile health platform connecting patients with healthcare providers through telemedicine and AI-powered health monitoring.

Valuation

฿100M

Employees

25

Patents

3

Revenue

฿5M

Investors

True Digital VenturesBeacon VCAngel Investor GroupHealth Tech Accelerator

Use of Funds

Platform development
User acquisition
Team expansion
Regulatory compliance
8 partnerships
Early stage

BioMaterials Research Co.

Pre-Series ABiomaterialsDevelopment

Led by TCELS Venture Capital

฿35M
$1.0M
8/14/2023

Developing biodegradable medical implants using innovative biomaterials for enhanced patient outcomes.

Valuation

฿140M

Employees

35

Patents

6

Revenue

฿2M

Investors

TCELS Venture CapitalUniversity Innovation FundGreen Tech VenturesImpact Investment Thailand

Use of Funds

Research & development
Prototype development
Clinical trials preparation
IP portfolio

Funding History

SeedUniversity Innovation Fund
฿8M
4/12/2022
4 partnerships
Development stage